BBP

Virtus LifeSci Biotech Products ETF · PSE

  • Category Health Care
  • Expense Ratio 0.79%
  • Listing Date Dec 17, 2014
  • Volume 2,692.0
  • Market Cap (AUM) $21.03M

Performance

-0.83%

1W

-3.82%

1M

-2.38%

3M

-6.17%

6M

+0.1%

YTD

+7.72%

1Y

Top Holdings

  • Name
    Symbol
    %Assets
  • ADMA Biologics, Inc.ADMA5.07%
  • Insmed IncorporatedINSM4.05%
  • Agios Pharmaceuticals, Inc.AGIO3.82%
  • Tarsus Pharmaceuticals, Inc.TARS3.29%
  • Moderna, Inc.MRNA3.21%
  • Lexicon Pharmaceuticals, Inc.LXRX2.67%
  • PTC Therapeutics, Inc.PTCT2.54%
  • Sarepta Therapeutics, Inc.SRPT2.51%
  • Blueprint Medicines Corp.BPMC2.41%
  • Halozyme Therapeutics, Inc.HALO2.39%

Technical Analysis of BBP 2025-03-13

The stock indicators suggest a predominantly bearish sentiment, with a Moving Average Score of 0 indicating strong downward pressure, while the Oscillators Score of 41 reflects a neutral stance, and the overall Technical Score of 20 reinforces the bearish outlook. This combination implies that caution is warranted as the stock may face continued...
Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

See more ...

Recent News & Updates

Disclaimer: The information provided here and on kavout.com is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout makes no recommendations regarding investment decisions based on this information. You are solely responsible for your investments. Please conduct your own research and consult qualified financial advisors before investing. Past performance does not guarantee future results.